Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulation

Leukemia. 2012 Jun;26(6):1425-9. doi: 10.1038/leu.2011.359. Epub 2011 Dec 23.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Immune Tolerance / immunology*
  • Lenalidomide
  • Myelodysplastic Syndromes / drug therapy*
  • Myelodysplastic Syndromes / immunology*
  • Prognosis
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology*
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide